Loading company details...
Beta
Latest Form 4 (Sep 21, 2026): RA CAPITAL MANAGEMENT, L.P. (Director): Sale of 3,415,011 shares, $21.58M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | RA CAPITAL MANAGEMENT, L.P. | Sale | 3,415,011 | $21.58M |
| Sep 18, 2026 | Elena Ridloff, CFO and CBO | Grant/Award | 47,269 | n/a |
| Sep 18, 2026 | Charlotte McKee, CMO and Head of R&D | Grant/Award | 50,000 | n/a |
| Sep 18, 2026 | Jennifer Fitzpatrick, CLO and Head of Program Mgmt. | Grant/Award | 28,133 | n/a |
| Sep 18, 2026 | Michael Cloonan, President & CEO | Grant/Award | 109,025 | n/a |
| Jul 9, 2026 | Peter A. Thompson | Sale | 85,918 | $3.85M |
| Jul 9, 2026 | ORBIMED ADVISORS LLC | Sale | 85,918 | $3.85M |
| Jul 7, 2026 | Jennifer Fitzpatrick, Chief Legal Officer | Exercise/Conversion | 10,250 | $62.6K |
| Jul 2, 2026 | Peter A. Thompson | Sale | 115,844 | $5.27M |
| Jul 2, 2026 | ORBIMED ADVISORS LLC | Sale | 115,844 | $5.27M |